74 related articles for article (PubMed ID: 22406264)
1. Protein disulfide isomerase-mediated disulfide bonds regulate the gelatinolytic activity and secretion of matrix metalloproteinase-9.
Khan MM; Simizu S; Suzuki T; Masuda A; Kawatani M; Muroi M; Dohmae N; Osada H
Exp Cell Res; 2012 May; 318(8):904-14. PubMed ID: 22406264
[TBL] [Abstract][Full Text] [Related]
2. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
3. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
5. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
6. Human pancreas-specific protein disulfide isomerase homolog (PDIp) is redox-regulated through formation of an inter-subunit disulfide bond.
Fu X; Zhu BT
Arch Biochem Biophys; 2009 May; 485(1):1-9. PubMed ID: 19150607
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.
Puente XS; Pendás AM; Llano E; Velasco G; López-Otín C
Cancer Res; 1996 Mar; 56(5):944-9. PubMed ID: 8640782
[TBL] [Abstract][Full Text] [Related]
8. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
10. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.
Klein G; Vellenga E; Fraaije MW; Kamps WA; de Bont ES
Crit Rev Oncol Hematol; 2004 May; 50(2):87-100. PubMed ID: 15157658
[TBL] [Abstract][Full Text] [Related]
11. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
[TBL] [Abstract][Full Text] [Related]
12. Construction, expression, and characterization of a baculovirally expressed catalytic domain of human matrix metalloproteinase-9.
Sadatmansoori S; MacDougall J; Khademi S; Cooke LS; Guarino L; Meyer EF; Forough R
Protein Expr Purif; 2001 Dec; 23(3):447-52. PubMed ID: 11722182
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways.
Sen T; Dutta A; Maity G; Chatterjee A
Biochimie; 2010 Oct; 92(10):1422-34. PubMed ID: 20638438
[TBL] [Abstract][Full Text] [Related]
14. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan.
Zhong D; Saito F; Saito Y; Nakamura A; Shimizu T; Matsumura K
Biochem Biophys Res Commun; 2006 Jun; 345(2):867-71. PubMed ID: 16701552
[TBL] [Abstract][Full Text] [Related]
16. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
17. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
[TBL] [Abstract][Full Text] [Related]
18. Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages.
Velot E; Haas B; Léonard F; Ernens I; Rolland-Turner M; Schwartz C; Longrois D; Devaux Y; Wagner DR
Cardiovasc Res; 2008 Nov; 80(2):246-54. PubMed ID: 18653544
[TBL] [Abstract][Full Text] [Related]
19. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
Uría JA; López-Otín C
Cancer Res; 2000 Sep; 60(17):4745-51. PubMed ID: 10987280
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E
J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
